Last Updated: September 28, 2026

Jubilant Generics Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for JUBILANT GENERICS

JUBILANT GENERICS has forty-nine approved drugs.

Summary for Jubilant Generics

US Patents:	0
Tradenames:	44
Ingredients:	43
NDAs:	49

Drugs and US Patents for Jubilant Generics

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Jubilant Generics	LURASIDONE HYDROCHLORIDE	lurasidone hydrochloride	TABLET;ORAL	210388-005	Dec 6, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant Generics	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	090901-001	Aug 30, 2011		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant Generics	TADALAFIL	tadalafil	TABLET;ORAL	210329-004	May 15, 2026	AB1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant Generics	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	207459-001	Jun 30, 2017		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant Generics	CITALOPRAM HYDROBROMIDE	citalopram hydrobromide	TABLET;ORAL	205407-003	Dec 23, 2015		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Jubilant Generics	OLANZAPINE	olanzapine	TABLET, ORALLY DISINTEGRATING;ORAL	200221-001	Sep 12, 2012	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.